ARCHIVES

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Pryor Bill Embodies Drug Company Fears

July 8, 1994

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996